QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
NASDAQ:GDRX

GoodRx (GDRX) Stock Forecast, Price & News

$5.53
+0.07 (+1.28%)
(As of 09/28/2023 ET)
Compare
Today's Range
$5.42
$5.58
50-Day Range
$5.40
$9.24
52-Week Range
$3.82
$9.37
Volume
751,055 shs
Average Volume
1.63 million shs
Market Capitalization
$2.20 billion
P/E Ratio
184.39
Dividend Yield
N/A
Price Target
$8.44

GoodRx MarketRank™ Forecast

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
52.6% Upside
$8.44 Price Target
Short Interest
Bearish
10.46% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.52mentions of GoodRx in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
25.00%
From $0.08 to $0.10 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.19 out of 5 stars

Medical Sector

371st out of 969 stocks

Data Processing & Preparation Industry

31st out of 58 stocks


GDRX stock logo

About GoodRx (NASDAQ:GDRX) Stock

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is headquartered in Santa Monica, California.

GDRX Price History

GDRX Stock News Headlines

Wall Street Legend Warns "Mass Bank Run" is Coming
Man who predicted 2023 bank run warns it could soon get worse. Get out of cash and into a new vehicle 50 years in the making. Click here to learn more.
ICLR vs. GDRX: Which Stock Is the Better Value Option?
What 15 Analyst Ratings Have To Say About GoodRx Holdings
Wall Street Legend Warns "Mass Bank Run" is Coming
Man who predicted 2023 bank run warns it could soon get worse. Get out of cash and into a new vehicle 50 years in the making. Click here to learn more.
GoodRx Holdings Inc.
13 Analysts Have This to Say About GoodRx Holdings
Credit Suisse Reaffirms Their Hold Rating on GoodRx Holdings (GDRX)
GoodRx (GDRX) Q2 2023 Earnings Call Transcript
GoodRx Holdings Q2 Adj. Profit Rises
See More Headlines
Receive GDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter.

GDRX Company Calendar

Last Earnings
8/09/2023
Today
9/28/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GDRX
Fax
N/A
Employees
952
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.44
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$6.50
Forecasted Upside/Downside
+51.8%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
14 Analysts

Profitability

Net Income
$-32,830,000.00
Pretax Margin
-1.52%

Debt

Sales & Book Value

Annual Sales
$766.55 million
Cash Flow
$0.23 per share
Book Value
$2.05 per share

Miscellaneous

Free Float
392,395,000
Market Cap
$2.21 billion
Optionable
Not Optionable
Beta
1.13
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Trevor BezdekMr. Trevor Bezdek (Age 45)
    Co-founder & Chairman
    Comp: $537k
  • Mr. Douglas Joseph HirschMr. Douglas Joseph Hirsch (Age 52)
    Co-founder, Chief Mission Officer & Director
    Comp: $507.29k
  • Mr. Karsten Ian VoermannMr. Karsten Ian Voermann (Age 53)
    CFO & Principal Financial Officer
    Comp: $693.69k
  • Mr. Raj Beri (Age 48)
    Chief Operating Officer
    Comp: $1.11M
  • Mr. Romin Nabiey (Age 36)
    Chief Accounting Officer & Principal Accounting Officer
    Comp: $516k
  • Mr. Scott W. Wagner (Age 52)
    Interim Chief Exec. Officer
  • Ms. Whitney Notaro
    VP of Investor Relations
  • Mr. Andrew SlutskyMr. Andrew Slutsky (Age 36)
    Chief Marketing Officer
  • Ms. Vina M. Leite (Age 53)
    Chief People Officer
  • Mr. Bansi NagjiMr. Bansi Nagji (Age 58)
    Pres of Healthcare













GDRX Stock - Frequently Asked Questions

Should I buy or sell GoodRx stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GoodRx in the last year. There are currently 9 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GDRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GDRX, but not buy additional shares or sell existing shares.
View GDRX analyst ratings
or view top-rated stocks.

What is GoodRx's stock price forecast for 2023?

14 brokers have issued 12-month target prices for GoodRx's shares. Their GDRX share price forecasts range from $6.50 to $12.00. On average, they expect the company's stock price to reach $8.44 in the next twelve months. This suggests a possible upside of 51.8% from the stock's current price.
View analysts price targets for GDRX
or view top-rated stocks among Wall Street analysts.

How have GDRX shares performed in 2023?

GoodRx's stock was trading at $4.66 on January 1st, 2023. Since then, GDRX shares have increased by 19.3% and is now trading at $5.56.
View the best growth stocks for 2023 here
.

When is GoodRx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our GDRX earnings forecast
.

How were GoodRx's earnings last quarter?

GoodRx Holdings, Inc. (NASDAQ:GDRX) issued its quarterly earnings data on Wednesday, August, 9th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.01. The business had revenue of $189.68 million for the quarter, compared to analyst estimates of $186.90 million. GoodRx had a net margin of 1.58% and a trailing twelve-month return on equity of 2.44%.

What ETFs hold GoodRx's stock?
What guidance has GoodRx issued on next quarter's earnings?

GoodRx issued an update on its third quarter 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $186.00 million-$190.00 million, compared to the consensus revenue estimate of $192.58 million.

What other stocks do shareholders of GoodRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GoodRx investors own include Gilead Sciences (GILD), NVIDIA (NVDA), AbbVie (ABBV), Bristol-Myers Squibb (BMY), DraftKings (DKNG), GW Pharmaceuticals (GWPH), Rocket Companies (RKT), AT&T (T), Advanced Micro Devices (AMD) and Alteryx (AYX).

When did GoodRx IPO?

(GDRX) raised $900 million in an IPO on Wednesday, September 23rd 2020. The company issued 34,600,000 shares at a price of $24.00-$28.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays acted as the underwriters for the IPO and BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI, Citizens Capital Markets, KKR, LionTree, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus and Ramirez were co-managers.

What is GoodRx's stock symbol?

GoodRx trades on the NASDAQ under the ticker symbol "GDRX."

Who are GoodRx's major shareholders?

GoodRx's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (0.63%), BlackRock Inc. (0.52%), Dimensional Fund Advisors LP (0.31%), Assenagon Asset Management S.A. (0.30%), Rip Road Capital Partners LP (0.24%) and ExodusPoint Capital Management LP (0.23%). Insiders that own company stock include Abdiel Capital Management, Llc, Agnes Rey-Giraud, Andrew Slutsky, Babak Azad, Bansi Nagji, Douglas Joseph Hirsch, Idea Men, Llc, Karsten Voermann, Lake Group LLC Silver and Trevor Bezdek.
View institutional ownership trends
.

How do I buy shares of GoodRx?

Shares of GDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GoodRx's stock price today?

One share of GDRX stock can currently be purchased for approximately $5.56.

How much money does GoodRx make?

GoodRx (NASDAQ:GDRX) has a market capitalization of $2.21 billion and generates $766.55 million in revenue each year. The company earns $-32,830,000.00 in net income (profit) each year or $0.03 on an earnings per share basis.

How many employees does GoodRx have?

The company employs 952 workers across the globe.

How can I contact GoodRx?

GoodRx's mailing address is 233 WILSHIRE BLVD. SUITE 990, SANTA MONICA CA, 90401. The official website for the company is www.goodrx.com. The company can be reached via phone at 855-268-2822 or via email at alex@blueshirtgroup.com.

This page (NASDAQ:GDRX) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -